Steve Levine
Chief Patient Officer COMPASS Pathways
Steve is a board-certified psychiatrist who has spent his career working across multiple facets of the healthcare system to improve people’s lives through creating access to innovation.
Steve completed internship and residency in psychiatry at New York – Presbyterian Hospital / Weill Cornell Medical Center. He then completed fellowship subspecialty training in psychosomatic medicine / psycho-oncology at Memorial Sloan Kettering Cancer Center/New York – Presbyterian Hospital. Prior to Compass, he led the company he founded in 2010, Actify Neurotherapies, that built new models of care delivery across the US for interventional psychiatry treatments. He has published extensively in both peer-reviewed journals and popular media, presented to both professional and lay audiences around the world, served in leadership roles for professional societies and not-for-profit entities, and received numerous awards for leadership and service.
Seminars
Interventional psychiatry is advancing rapidly, but commercializing new treatments in this space requires navigating scientific complexity, clinical-workflow integration, regulatory ambiguity and evolving payer expectations. This workshop brings together leaders across drug development, clinical services, digital therapeutics and health-system innovation to unpack what it takes to bring interventional psychiatric treatments to market effectively and responsibly. Through real-world case studies and cross-sector perspectives, attendees will explore how to position novel modalities, build scalable delivery models, integrate biomarkers and patient-selection tools, evaluate reimbursement pathways, and ensure safe, consistent implementation across diverse clinical environments.
- Define the commercial, clinical and operational considerations required to bring interventional psychiatric treatments to market, including positioning, differentiation and workflow integration
- Examine the infrastructure, training, safety and scalability requirements needed for real-world delivery across clinics, health systems and community-based care settings
- Identify viable reimbursement and market-access pathways by understanding payer priorities, value demonstration, and the evidence needed to support sustainable adoption
Interventional psychiatry is advancing rapidly, but commercializing new treatments in this space requires navigating scientific complexity, clinical workflow integration, regulatory ambiguity and evolving payer expectations. This workshop brings together leaders across drug development, clinical services, digital therapeutics and health system innovation to unpack what it takes to bring interventional psychiatric treatments to market effectively and responsibly. Through real world case studies and cross sector perspectives, attendees will explore how to position novel modalities, build scalable delivery models, integrate biomarkers and patient selection tools, evaluate reimbursement pathways, and ensure safe, consistent implementation across diverse clinical environments.
- Define the commercial, clinical and operational considerations required to bring interventional psychiatric treatments to market, including positioning, differentiation and workflow integration
- Examine the infrastructure, training, safety and scalability requirements needed for real world delivery across clinics, health systems and community based care settings
- Identify viable reimbursement and market access pathways by understanding payer priorities, value demonstration, and the evidence needed to support sustainable adoption
